Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Mao YP, Wang SX, Gao TS, Zhang N, Liang XY, Xie FY, Zhang Y, Zhou GQ, Guo R, Luo WJ, Li YJ, Liang SQ, Lin L, Li WF, Liu X, Xu C, Chen YP, Lv JW, Huang SH, Liu LZ, Li JB, Tang LL, Chen L, Sun Y, Ma J.
Mao YP, et al. Among authors: lv jw.
BMJ. 2023 Feb 6;380:e072133. doi: 10.1136/bmj-2022-072133.
BMJ. 2023.
PMID: 36746459
Free PMC article.
Clinical Trial.